Works by Hideki Takeshita


Results: 52
    1
    2
    4
    5
    6
    7
    8

    Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 5, p. 747, doi. 10.1007/s11523-024-01089-2
    By:
    • Rizzo, Alessandro;
    • Monteiro, Fernando Sabino Marques;
    • Ürün, Yüksel;
    • Massari, Francesco;
    • Park, Se Hoon;
    • Bourlon, Maria T.;
    • Poprach, Alexandr;
    • Rizzo, Mimma;
    • Takeshita, Hideki;
    • Giannatempo, Patrizia;
    • Soares, Andrey;
    • Roviello, Giandomenico;
    • Molina-Cerrillo, Javier;
    • Carrozza, Francesco;
    • Abahssain, Halima;
    • Messina, Carlo;
    • Kopp, Ray Manneh;
    • Pichler, Renate;
    • Formisano, Luigi;
    • Tural, Deniz
    Publication type:
    Article
    9

    Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03682-w
    By:
    • Massari, Francesco;
    • Santoni, Matteo;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Tapia, Jose Carlos;
    • Basso, Umberto;
    • Maruzzo, Marco;
    • Scagliarini, Sarah;
    • Büttner, Thomas;
    • Fornarini, Giuseppe;
    • Myint, Zin W.;
    • Galli, Luca;
    • Souza, Vinicius Carrera;
    • Pichler, Renate;
    • De Giorgi, Ugo;
    • Gandur, Nathalia;
    • Lam, Elaine T.;
    • Gilbert, Danielle;
    • Popovic, Lazar;
    • Grande, Enrique
    Publication type:
    Article
    10

    Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3665, doi. 10.1007/s00262-023-03518-z
    By:
    • Fiala, Ondřej;
    • Buti, Sebastiano;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Massari, Francesco;
    • Palacios, Georgia Anguera;
    • Dionese, Michele;
    • Scagliarini, Sarah;
    • Büttner, Thomas;
    • Fornarini, Giuseppe;
    • Myint, Zin W.;
    • Galli, Luca;
    • Souza, Vinicius Carrera;
    • Pichler, Renate;
    • De Giorgi, Ugo;
    • Quiroga, María Natalia Gandur;
    • Gilbert, Danielle;
    • Popovic, Lazar;
    • Grande, Enrique;
    • Mammone, Giulia
    Publication type:
    Article
    11

    Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2961, doi. 10.1007/s00262-023-03469-5
    By:
    • Santoni, Matteo;
    • Myint, Zin W.;
    • Büttner, Thomas;
    • Takeshita, Hideki;
    • Okada, Yohei;
    • Lam, Elaine T.;
    • Gilbert, Danielle;
    • Küronya, Zsófia;
    • Tural, Deniz;
    • Pichler, Renate;
    • Grande, Enrique;
    • Crabb, Simon J.;
    • Kemp, Robert;
    • Massari, Francesco;
    • Scagliarini, Sarah;
    • Iacovelli, Roberto;
    • Vau, Nuno;
    • Basso, Umberto;
    • Maruzzo, Marco;
    • Molina-Cerrillo, Javier
    Publication type:
    Article
    12
    13

    Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study.

    Published in:
    Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5413, doi. 10.1007/s10238-023-01235-6
    By:
    • Santoni, Matteo;
    • Massari, Francesco;
    • Takeshita, Hideki;
    • Tapia, Jose Carlos;
    • Dionese, Michele;
    • Pichler, Renate;
    • Rizzo, Mimma;
    • Lam, Elaine T.;
    • Grande, Enrique;
    • Kemp, Robert;
    • Molina-Cerrillo, Javier;
    • Calabrò, Fabio;
    • Tural, Deniz;
    • Küronya, Zsófia;
    • Kucharz, Jakub;
    • Fiala, Ondrej;
    • Seront, Emmanuel;
    • Kopp, Ray Manneh;
    • Abahssain, Halima;
    • Kopecky, Jindrich
    Publication type:
    Article
    14
    15
    16
    17
    18
    19

    Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2<sup>EV</sup> study.

    Published in:
    Clinical & Experimental Metastasis, 2025, v. 42, n. 2, p. 1, doi. 10.1007/s10585-025-10335-4
    By:
    • Fiala, Ondřej;
    • Buti, Sebastiano;
    • Fujita, Kazutoshi;
    • de Liaño, Alfonso Gómez;
    • Fukuokaya, Wataru;
    • Kimura, Takahiro;
    • Yanagisawa, Takafumi;
    • Giannatempo, Patrizia;
    • Angel, Martin;
    • Mennitto, Alessia;
    • Molina-Cerrillo, Javier;
    • Bourlon, Maria T.;
    • Soares, Andrey;
    • Takeshita, Hideki;
    • Calabrò, Fabio;
    • Ortega, Cinzia;
    • Kucharz, Jakub;
    • Milella, Michele;
    • Seront, Emmanuel;
    • Park, Se Hoon
    Publication type:
    Article
    20
    21

    Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 12, p. 1651, doi. 10.1007/s10147-023-02406-x
    By:
    • Washino, Satoshi;
    • Shirotake, Suguru;
    • Takeshita, Hideki;
    • Inoue, Masaharu;
    • Miura, Yuji;
    • Hyodo, Yoji;
    • Kagawa, Makoto;
    • Izumi, Keita;
    • Oyama, Masafumi;
    • Kawakami, Satoru;
    • Saito, Kazutaka;
    • Matsuoka, Yoh;
    • Taniuchi, Satsuki;
    • Shintani, Ayumi;
    • Miyagawa, Tomoaki
    Publication type:
    Article
    22
    23

    Real‐Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON‐2 Retrospective Experience.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 4, p. 1, doi. 10.1002/cam4.70479
    By:
    • Rizzo, Mimma;
    • Morelli, Franco;
    • Ürün, Yüksel;
    • Buti, Sebastiano;
    • Park, Se Hoon;
    • Bourlon, Maria T.;
    • Grande, Enrique;
    • Massari, Francesco;
    • Landmesser, Johannes;
    • Poprach, Alexandr;
    • Takeshita, Hideki;
    • Roviello, Giandomenico;
    • Myint, Zin W.;
    • Popovic, Lazar;
    • Soares, Andrey;
    • Abahssain, Halima;
    • Giannatempo, Patrizia;
    • Molina‐Cerrillo, Javier;
    • Incorvaia, Lorena;
    • Salah, Samer
    Publication type:
    Article
    24

    Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70182-3
    By:
    • Rizzo, Mimma;
    • Soares, Andrey;
    • Grande, Enrique;
    • Bamias, Aristotelis;
    • Kopp, Ray Manneh;
    • Lenci, Edoardo;
    • Buttner, Thomas;
    • Salah, Samer;
    • Grillone, Francesco;
    • de Carvalho, Icaro Thiago;
    • Tapia, Jose Carlos;
    • Gucciardino, Calogero;
    • Pinto, Alvaro;
    • Mennitto, Alessia;
    • Abahssain, Halima;
    • Rescigno, Pasquale;
    • Myint, Zin;
    • Takeshita, Hideki;
    • Spinelli, Gian Paolo;
    • Popovic, Lazar
    Publication type:
    Article
    25
    26
    27

    A CASE OF PENILE VERRUCOUS CARCINOMA: DIAGNOSTIC DIFFICULTIES WITH BIOPSY.

    Published in:
    Japanese Journal of Urology / Nihon Hinyokika Gakkai Zasshi, 2025, v. 116, n. 2, p. 50
    By:
    • Ayano Ishida;
    • Hideki Takeshita;
    • Takahisa Yamashita;
    • Junya Kawabata;
    • Kojiro Tachibana;
    • Shoichi Nagamoto;
    • Sachi Kitayama;
    • Yohei Okada;
    • Akihiro Yano;
    • Shinsaku Kumagai;
    • Morihiro Higashi;
    • Satoru Kawakami
    Publication type:
    Article
    28
    29
    30
    31
    32

    Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-93094-2
    By:
    • Incorvaia, Lorena;
    • Scagliarini, Sarah;
    • Marques Monteiro, Fernando Sabino;
    • Takeshita, Hideki;
    • Tapia, Jose Carlos;
    • Gandur Quiroga, María Natalia;
    • Lam, Elaine;
    • Tural, Deniz;
    • Popovic, Lazar;
    • Campos-Gomez, Saul;
    • Zucali, Paolo Andrea;
    • Mota, Augusto;
    • Ortega, Cinzia;
    • Sade, Juan Pablo;
    • Rizzo, Mimma;
    • Fiala, Ondřej;
    • Vau, Nuno;
    • Giannatempo, Patrizia;
    • Abahssain, Halima;
    • Galosi, Andrea Benedetto
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39

    Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer.

    Published in:
    International Urology & Nephrology, 2014, v. 46, n. 3, p. 555, doi. 10.1007/s11255-013-0557-1
    By:
    • Bae, Hyeyeol;
    • Yoshida, Soichiro;
    • Matsuoka, Yoh;
    • Nakajima, Hiroshi;
    • Ito, Eisaku;
    • Tanaka, Hiroshi;
    • Oya, Miyako;
    • Nakayama, Takayuki;
    • Takeshita, Hideki;
    • Kijima, Toshiki;
    • Ishioka, Junichiro;
    • Numao, Noboru;
    • Koga, Fumitaka;
    • Saito, Kazutaka;
    • Akashi, Takumi;
    • Fujii, Yasuhisa;
    • Kihara, Kazunori
    Publication type:
    Article
    40
    41
    42

    Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non‐clear cell renal cell carcinoma: Real‐world data from a Japanese multicenter retrospective study.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 9, p. 714, doi. 10.1111/iju.15128
    By:
    • Izumi, Keita;
    • Inoue, Masaharu;
    • Washino, Satoshi;
    • Shirotake, Suguru;
    • Kagawa, Makoto;
    • Takeshita, Hideki;
    • Miura, Yuji;
    • Hyodo, Yoji;
    • Oyama, Masafumi;
    • Kawakami, Satoru;
    • Miyagawa, Tomoaki;
    • Saito, Kazutaka;
    • Kageyama, Yukio
    Publication type:
    Article
    43

    Treatment strategies and outcomes in a long‐term registry study of patients with high‐risk metastatic hormone‐naïve prostate cancer in Japan: An interim analysis of the J‐ROCK study.

    Published in:
    International Journal of Urology, 2022, v. 29, n. 9, p. 1061, doi. 10.1111/iju.14993
    By:
    • Uemura, Hirotsugu;
    • Matsumoto, Rikiya;
    • Mizokami, Atsushi;
    • Miyake, Hideaki;
    • Uemura, Hiroji;
    • Matsuyama, Hideyasu;
    • Nakamura, Kazuyoshi;
    • Saito, Kazutaka;
    • Kawakita, Mutsushi;
    • Takeshita, Hideki;
    • Koroki, Yosuke;
    • Ono, Shintaro;
    • Murota, Maiko;
    • Ito, Miku;
    • Kamoto, Toshiyuki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50